CN¥ 31.76
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable price performance
About
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/E
Target Price
The average target price of 300759.SZ is 36 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
